Haohai Biological Technology shareholder notified of penalty for alleged insider trading

Shanghai Haohai Biological Technology Co., Ltd. announced on September 17, 2025, that its controlling shareholder and actual controller, Mr. Jiang Wei, received a "Prior Notice of Administrative Penalty" from the China Securities Regulatory Commission. This follows an earlier "Case Filing Notice" issued in May 2025 regarding alleged insider trading. The company emphasized that the matter pertains to Mr. Jiang Wei personally and does not involve the company, nor does it affect its daily operations, business, or financial performance.

In a related disclosure, the company reported share repurchase activities. On September 16, 2025, a total of 10,000 H shares were repurchased on the Hong Kong Stock Exchange at HK$27.68 per share, amounting to HK$276,800. These shares are intended for cancellation. The repurchases are part of an authorization approved on June 10, 2025, allowing for the repurchase of up to 3,914,184 shares, with 77,400 shares already repurchased to date.